Pip5k1c expression in osteocytes regulates bone remodeling in mice

Sixiong Lin1,2, Chu Tao2, Qinnan Yan2

  • 1Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Department of Spinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Summary

Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma (Pip5k1c) is crucial for maintaining bone mass. Loss of Pip5k1c in osteocytes impairs bone formation and impacts collagen and sclerostin levels, suggesting a therapeutic target for metabolic bone diseases.